The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography
Open accessAbstract
We provide the first evidence for the capability of a high-resolution positron emission tomographic (PET) imaging system in quantitatively mapping amyloid accumulation in living amyloid precursor protein transgenic (Tg) mice. After the intravenous administration of N-[11 C]methyl-2-(4′-methylaminophenyl)-6-hydroxybenzothiazole (or [11 C]PIB for “Pittsburgh Compound-B”) with high-specific radioactivity, the Tg mice exhibited high-level retention of radioactivity in amyloid-rich regions. PET investigation for Tg mice over an extended range of ages, including longitudinal assessments, demonstrated age-dependent increase in radioligand binding consistent with progressive amyloid accumulation. Reduction in amyloid levels in the hippocampus of Tg mice was also successfully monitored by multiple PET scans along the time course of anti-amyloid treatment using an antibody against amyloid β peptide (Aβ). Moreover, PET scans with [18 F]fluoroethyl-DAA1106, a radiotracer for activated glia, were conducted for these individuals parallel to amyloid imaging, revealing treatment-induced neuroinflammatory responses, the magnitude of which intimately correlated with the levels of pre-existing amyloid estimated by [11 C]PIB. It is also noteworthy that the localization and abundance of [11 C]PIB autoradiographic signals were closely associated with those of N-terminally truncated and modified Aβ, AβN3-pyroglutamate, in Alzheimer's disease (AD) and Tg mouse brains, implying that the detectability of amyloid by [11 C]PIB positron emission tomography is dependent on the accumulation of specific Aβ subtypes. Our results support the usefulness of the small animal-dedicated PET system in conjunction with high-specific radioactivity probes and appropriate Tg models not only for clarifying the mechanistic properties of amyloidogenesis in mouse models but also for preclinical tests of emerging diagnostic and therapeutic approaches to AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“interestingly vascular amyloid is somewhat different in its composition 79 and potentially, its conformation from the parenchymal Aβ plaques 92 .”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Self-citationDistribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G., Ding, Y., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,515
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citationIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Orgogozo, J.-M., Gilman, S., Dartigues, J.-F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000073623.84147.a8 · Cited by 1,356
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053
Self-citation[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Cited by
Sorted by citations
Items 201–300 of 302
Biopsy Support for the Validity of Pittsburgh Compound B Positron Emission Tomography With a Twist
Klunk, W. E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1281 · Cited by 12
Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
Wang, P., Lin, K., Liu, H., Andréasson, U., Blennow, K., Zetterberg, H., & Yang, S. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12029 · Cited by 11
Amyloid plaque imaging from IMPY/SPECT to AV-45/PET
Kung, M., Lin, K., Hsiao, I., Weng, C.-C., Yen, T., & Wey, S. (2012) · Biomedical Journal · doi:10.4103/2319-4170.106151 · Cited by 11
Basic Science of PET Imaging for Inflammatory Diseases
Kubota, K., Ogawa, M., Ji, B., Watabe, T., Zhang, M., Suzuki, H., Sawada, M., Nishi, K., & Kudo, T. (2019) · Springer eBooks · doi:10.1007/978-981-15-0810-3_1 · Cited by 12
Self-citationAmyloid imaging in Alzheimer's disease: A literature review
Saidlitz, P., Voisin, T., Vellas, B. J., Payoux, P., Gabelle, A., Formaglio, M., & Delrieu, J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0507-3 · Cited by 12
Chen, C., Bando, K., Ashino, H., Taguchi, K., Shiraishi, H., Shima, K., Fujimoto, O., Kitamura, C., Morimoto, Y., Kasahara, H., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.08.036 · Cited by 11
Self-citationMaier, F. C., Keller, M., Bukala, D., Bender, B., Mannheim, J. G., Brereton, I. M., Galloway, G. J., & Pichler, B. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.159350 · Cited by 10
Kincses, Z. T., Király, A., Veréb, D., & Vécsei, L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143195 · Cited by 10
Ni, R., Chen, Z., Shi, G., Villois, A., Zhou, Q., Arosio, P., Nitsch, R. M., Nilsson, K. P. R., Klohs, J., & Razansky, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.01.929844 · Cited by 10
A simple and efficient automated microvolume radiosynthesis of [18F]Florbetaben
Lisova, K., Wang, J., Chao, P. H., & van Dam, R. M. (2020) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-020-00113-w · Cited by 9
Neurobiology of Alzheimer’s Disease
Wong, P. C., Savonenko, A. V., Li, T., & Price, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00046-8 · Cited by 9
Qin, Q., Fu, L., Wang, R., Lyu, J., Ma, H., Zhan, M., Zhou, A., Wang, F., Zuo, X., & Wei, C. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.732159 · Cited by 8
In vivo imaging of neuroinflammation in Alzheimer's disease
Higuchi, M., Ji, B., Maeda, J., Sahara, N., & Suhara, T. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12308 · Cited by 8
Self-citationWaldron, A., Verhaeghe, J. A. J., Wyffels, L., Schmidt, M. E., Langlois, X., der Linden, A. V., Stroobants, S. G., & Staelens, S. G. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0833-9 · Cited by 9
Ankul Singh, S., Ansari, M. N., Elossaily, G. M., Vellapandian, C., & Prajapati, B. G. (2024) · ACS Omega · doi:10.1021/acsomega.3c06328 · Cited by 7
PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease
Camargo, L. C., Schöneck, M., Sangarapillai, N., Honold, D., Shah, N. J., Langen, K., Willbold, D., Kutzsche, J., Schemmert, S., & Willuweit, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137062 · Cited by 7
Lee, J.-S., Su, K., Chang, W.-Y., & Chen, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.061 · Cited by 7
Barthe, N., Maîtrejean, S., Carvou, N., & Cardona, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814395-7.00009-x · Cited by 7
Cohen, A. D., & Villemagne, V. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70291 · Cited by 7
Iwata, N., Tsubuki, S., Sekiguchi, M., Watanabe-Iwata, K., Matsuba, Y., Kamano, N., Fujioka, R., Takamura, R., Watamura, N., Kakiya, N., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402650 · Cited by 8
Self-citationNeuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease
Suzuki, H., Kubota, M., Kurose, S., Tagai, K., Endo, H., Onaya, M., Yamamoto, Y., Sahara, N., Ohgidani, M., Haga, C., et al. (2025) · EJNMMI Research · doi:10.1186/s13550-025-01296-6 · Cited by 6
Self-citationTico, M. (2009) · InTech eBooks · doi:10.5772/7458 · Cited by 6
Fluorescence and Cerenkov luminescence imaging. Applications in small animal research.
Schwenck, J., Fuchs, K., Eilenberger, S. H. L., Rolle, A.-M., Vega, S. C., Thaiss, W. M., & Maier, F. C. (2016) · PubMed · Cited by 6
Neuroimaging in Dementia: In Vivo Amyloid Imaging
Suhara, T., Higuchi, M., & Miyoshi, M. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.215.119 · Cited by 7
Self-citationIn Vivo Mouse Imaging and Spectroscopy in Drug Discovery
Beckmann, N., Cannet, C., Rausch, M., Kneuer, R., & Gremlich, H. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0134-7_15 · Cited by 6
Challenges in Alzheimer’s Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences
Lombardi, G., Pupi, A., Bessi, V., Polito, C., Padiglioni, S., Ferrari, C., Lucidi, G., Berti, V., Cristofaro, M. T. D., Piaceri, I., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200119 · Cited by 5
Lack of occlusal support did not impact amyloid β deposition in APP knock-in mice
Murakami, A., Hara, T., Yamada-Kubota, C., Kuwahara, M., Ichikawa, T., & Minagi, S. (2021) · Journal of Prosthodontic Research · doi:10.2186/jpr.jpr_d_20_00205 · Cited by 5
Harasta, A. E., & Ittner, L. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_1 · Cited by 5
PET Applications in Animal Models of Neurodegenerative and Neuroinflammatory Disorders
Higuchi, M., Maeda, J., Ji, B., Tokunaga, M., Zhang, M., Maruyama, M., Ono, M., Fukumura, T., & Suhara, T. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_167 · Cited by 5
Self-citationSahara, N., & Lewis, J. M. (2010) · Future Neurology · doi:10.2217/fnl.10.10 · Cited by 5
Imaging in Neurology Research II: PET Imaging of CNS Disorders
Henriksen, G., & Drzezga, A. E. (2010) · Springer eBooks · doi:10.1007/978-3-642-12945-2_33 · Cited by 5
14 Amyloid Imaging and (What is “Normal”?) Aging
Klunk, W. E., & Mathis, C. A. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0014 · Cited by 5
Animal and Translational Models of Neurological Disorders: An Industrial Perspective
Hunter, A. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00013-8 · Cited by 5
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Wittnam, J. L. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3182 · Cited by 5
Glycolysis-enhancing α1-adrenergic antagonists are neuroprotective in Alzheimer’s diseasePreprint
Zhang, Q., Schultz, J. L., Simmering, J. E., Kirkpatrick, B. Q., Weber, M. A., Skuodas, S., Hicks, T. P., Pierce, G., Laughlin, M. H., Bertolli, A. X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.03.647018 · Cited by 5
Preclinical MRI and NMR Biomarkers of Alzheimer's Disease: Concepts and Applications
Dhénain, M. (2008) · Magnetic Resonance Insights · doi:10.4137/mri.s971 · Cited by 4
Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions
Villemagne, V. L., Fodero‐Tavoletti, M. T., Yates, P. A., Masters, C. L., & Rowe, C. C. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_10 · Cited by 4
Negative Amyloid PET Imaging in a Patient With Probable Alzheimer's Disease
Hellwig, S., Hüll, M., & Meyer, P. T. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182335e08 · Cited by 4
Dynamic In Vivo Imaging of Receptors in Small Animals Using Positron Emission Tomography
Johnström, P., Fryer, T. D., Bird, J., Richards, H. K., & Davenport, A. P. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-909-9_11 · Cited by 4
Genetically targeted reporter imaging of deep neuronal network in the mammalian brainPreprint
Shimojo, M., Ono, M., Takuwa, H., Mimura, K., Nagai, Y., Fujinaga, M., Kikuchi, T., Okada, M., Seki, C., Tokunaga, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.08.032870 · Cited by 4
Self-citationSuzuki, H., Tagai, K., Ono, M., Shimizu, H., Endo, H., Matsumoto, H., Kubota, M., Kataoka, Y., Moriguchi, S., Kurose, S., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241297382 · Cited by 3
Self-citationAnimal Models for Brain Research
Dam, D. V., & Deyn, P. P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_1 · Cited by 3
Currently Available Neuroimaging Approaches in Alzheimer Disease (AD) Early Diagnosis
Ortiz-Terán, L., Juan, M. R., Martin, M. D. L. N. C., & Ortiz, T. (2011) · InTech eBooks · doi:10.5772/17012 · Cited by 3
Influence of additives to the formulation of n.c.a. [11C]PiB on sterile filter performance
Patt, M., Solbach, C., Habermann, B., Schildan, A., Baur, B., & Sabri, O. (2013) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2013.09.004 · Cited by 3
Unique Challenges in The Development of Therapies for Neurological Disorders
O’Neill, G. N. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139032445.004 · Cited by 3
Nahimi, A., GJEDDE, A. H., Wong, D. F., Guilarte, T. R., Dziedzic, J., Valentine, H., Kim, J., Horti, A. G., & Wegener, G. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.77 · Cited by 3
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
Central Nervous System Drug Evaluation Using Positron Emission Tomography
Sekine, M., Maeda, J., Shimada, H., Nogami, T., Arakawa, R., Takano, H., Higuchi, M., Ito, H., Okubo, Y., & Suhara, T. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.1.9 · Cited by 2
Self-citationComparative Study in Different Filters for Efficient Sterile Filtration
An, H. H., Moon, B. S., Park, H. S., Lee, H. J., Lee, S. J., Oh, S. J., Kim, B. S., Lee, B. C., Lee, W. W., & Kim, S. E. (2020) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12073 · Cited by 2
Groot, C., Tolboom, N., Ikonomović, M. D., Lammertsma, A. A., Boon, B. D. C., Barkhof, F., Scheltens, P., Klunk, W. E., Rozemüller, A. J. M., Ossenkoppele, R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180316 · Cited by 2
Maeno, N. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001042 · Cited by 2
Ni, R. (2015) · Figshare · Cited by 2
Role of Metals in Alzheimer Disease
Roberts, B. R., & Bush, A. I. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch24 · Cited by 2
Positron Emission Tomography in Animal Models of Alzheimer’s Disease AmyloidosisPreprint
Ni, R. (2021) · Preprints.org · doi:10.20944/preprints202110.0222.v1 · Cited by 2
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation
Svedberg, M. M., Hellström‐Lindahl, E., Rahman, O., & Hall, H. (2012) · InTech eBooks · doi:10.5772/31813 · Cited by 1
Alternative pathways for production of β-amyloid peptides of Alzheimer's disease
HOOK, V. Y. H., Schechter, I., Demuth, H., & Hook, G. (2008) · Biological Chemistry · doi:10.1515/bc.2008.124_bchm.just-accepted · Cited by 1
Harada, R., Kudo, K., Soto, G. C., Iwata, R., Yanai, K., Taki, Y., Kudo, Y., Furumoto, S., & Okamura, N. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00882 · Cited by 1
Animal Models for Brain Research
Dam, D. V., & Deyn, P. P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_1 · Cited by 1
Applications of Small-Animal Imaging in Neurology and Psychiatry
Casteels, C., Zaidi, H., & Laere, K. V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0894-3_19 · Cited by 1
Alzheimer Disease: Protein Misfolding, Model Systems, and Experimental Therapeutics
Price, D. L., Savonenko, A. V., Li, T., Lee, M. K., & Wong, P. C. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch12 · Cited by 1
LeVine, H. (2010) · doi:10.1002/9780470572702.ch30 · Cited by 1
Le diagnostic de la maladie d’Alzheimer : l’apport de la recherche préclinique
Delatour, B., & Dhénain, M. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32835-3 · Cited by 2
Molecular Imaging by PET/SPECT
Ono, M. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.279 · Cited by 1
Self-citationBrainPET Poster Session: Radiotracers and Quantification
BERTOLDO, A., FLOREA, I., COBELLI, C., Piero, D., V, Panzacchi, A., Gilardi, M. C., Lenzi, G. L., Fazio, F., & Moresco, R. M. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.150 · Cited by 1
Identification of Novel Fluid Biomarkers for Alzheimer's Disease
Craig‐Schapiro, R. (2012) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7pr7t12
Amyloid imaging in Alzheimer´s disease and mild cognitive impairment by Positron Emission Tomography
Forsberg, A. (2008) · Figshare
In vivo imaging of amyloid plaques
Okamura, N., & Yanai, K. (2008) · Folia Pharmacologica Japonica · doi:10.1254/fpj.131.333
Marizzoni, M., Forloni, G., & Frisoni, G. B. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.09.003
Review Article Alzheimer's disease biomarkers in animal models: closing the translational gap
Sabbagh, J. J., Kinney, J. W., Cummings, J. L., & Ruvo, L. (2013)
Linking Molecular Neurobiology to Therapeutic Approaches for Alzheimer’s Disease with PET
Luiten, P. G. M., Masman, M. F., Dobos, N., Nyakas, C. J., de Vries, E. F. J., Dierckx, R., & Eisel, U. L. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_20
In-vivo imaging for pursuing molecular cascades in the pathogenesis of neurodegenerative diseases
Higuchi, M. (2009) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.49.929
Self-citationIwata, N., & Asai, M. (2012) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.52.1162
Self-citationIkonomovic, M. D., Abrahamson, E. E., Paljug, W. R., Klunk, L. W. E., Debnath, M. L., Cohen, A. D., Klunk, W. E., Price, J. C., Mathis, C. A., Hamilton, R. L., et al. (2012)
Molecular Imaging in Alzheimer Clinical Trials
Schmidt, M. E., Matthews, D. C., & Staelens, S. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00020-4
Price, D. L., Savonenko, A. V., Li, T., & Wong, P. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.009
Overview of Animal Models of Cancer, Neurodegenerative Disease and Inflammation
Toyohara, J., & Ishiwata, K. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814317740_0008
In Vivo Monitoring of Liposomal Encapsulated siRNA Delivery
Kenny, G. D. (2010) · Spiral (Imperial College London) · doi:10.25560/6208
Jeppsson, F. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
Richard, B. C. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5098
Imaging in Neurology Research III: Neurodegenerative Diseases
Endepols, H., & Neumaier, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-42202-2_30
赵, 雪. (2017) · International Journal of Psychiatry and Neurology · doi:10.12677/ijpn.2017.61001
Scarpini, E. A., & Galimberti, D. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1115351.571370
(2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32831cbb85
Amyloid imaging in alzheimer’s disease: A literature review
Saidlitz, P., Voisin, T., Vellas, B. J., Payoux, P., Gabelle, A., Formaglio, M., & Delrieu, J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0485-5
Preclinical Longitudinal In Vivo Biomarker Platform for Alzheimer’s Disease Drug Discovery
Kang, M. S., Zimmer, E. R., Ottoy, J., Shin, M., Woo, M. S., Aliaga, A., Massarweh, G., Cuello, A. C., Gauthier, S. G., & Rosa‐Neto, P. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.010
Perani, D. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718113640.793484091
Synthesis of 18F‐Labeled FC‐119S and Its Tosyl Precursor
Kato, K., Funasaka, M., Ogura, J., Minakawa, E. N., Seki, K., & Kumamoto, T. (2025) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.4145
Fujinaga, M., Ohkubo, T., Shimojo, M., Nagai, Y., Ono, M., Matsushita, Y., Mimura, K., Mori, W., Zhang, Y., Kurihara, Y., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00613 · Cited by 1
Self-citationSuhara, T. (2012) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.43.191
Self-citationAdditional file 1 of A simple and efficient automated microvolume radiosynthesis of [18F]Florbetaben
Lisova, K., Wang, J., Chao, P. H., & van Dam, R. M. (2020) · Figshare · doi:10.6084/m9.figshare.13336318
Stas, E., Yang, M., Schultz, S. R., & Go, M. A. (2026) · Journal of Biomedical Optics · doi:10.1117/1.jbo.31.1.016004
Freyssin, A. (2020) · theses.fr (ABES) · doi:10.70675/0db2e37dz547bz4731z852dz9b843c062cba
Caractérisation d'un nouveau mode de fixation de la protéine Tau aux microtubules
Khodja, L. A. (2022) · theses.fr (ABES) · doi:10.70675/d8b90a94z5fbdz4ca2za1edz18751d5575da
Joseph, S., Tavare, A., Thomas, K., Kim, D.-I., Timmins, K., Cantorias, M. V., Roman, B. M., Mroz, J., Baquero, J., Calderin, J., et al. (2026) · Molecules · doi:10.3390/molecules31122095
BindingDB (2012) · UC San Diego · doi:10.7270/q2jh3n50
Metadata
- Authors
- Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., Suzuki, K., Mori, H., Higuchi, M., & Suhara, T.
- Affiliations
- National Institute of Radiological Sciences (JP)
- Osaka City University (JP)
- Novartis (Switzerland) (CH)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Higuchi, Makoto
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-10-10
- Volume
- 27
- Issue
- 41
- Pages
- 10957-10968
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6672864
- OpenAlex
- W1984320700
- Cited by
- 300
- References
- 45
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 2 · 2022: 8 · 2021: 10 · 2020: 18 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 15 · 2014: 21 · 2013: 23 · 2012: 38
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (18023033, 18023040)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid imaging, Pittsburgh compound B, [11C]PIB, amyloid precursor protein transgenic mice, neuroinflammation, amyloid-beta, amyloid accumulation, hippocampus, longitudinal imaging
- MeSH terms
- Age Factors, Alzheimer Disease, Aniline Compounds, Animals, Antibodies, Disease Models, Animal, Female, Inflammation, Longitudinal Studies, Mice, Inbred C57BL, Mice, Transgenic, Thiazoles, Amyloid beta-Peptides, Neurofibrillary Tangles, Positron-Emission Tomography, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
